Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Guillemont

Jerome Emile Guillemont, Ande FR

Patent application numberDescriptionPublished
20090012108SALT OF 4-[[4-[[4-(2-CYANOETHENYL)-2,6-DIMETHYLPHENYL]AMINO]-2-PYRIMIDINYL]AMINO]BENZONITRILE - The present invention relates to a pharmaceutical composition comprising as active ingredient the hydrochloric acid salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethyl-phenyl]amino]-2-pyrimidinyl]amino]benzonitrile and to processes for their preparation.01-08-2009

Jerome Emile Georges Guillemont US

Patent application numberDescriptionPublished
201102304916-SUBSTITUTED 2-QUINOLINONES AND 2-QUINOXALINONES AS POLY(ADP-RIBOSE) POLYMERASE INHIBITORS - The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I)09-22-2011
201102304927-PHENYLALKYL SUBSTITUTED 2-QUINOLINONES AND 2-QUINOXALINONES AS POLY(ADP-RIBOSE) POLYMERASE INHIBITORS - The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I)09-22-2011

Jerôme Emile Georges Guillemont, Ande FR

Patent application numberDescriptionPublished
20100016317HIV INHIBITING 6-SUBSTITUTED PYRIMIDINES - HIV replication inhibitors of formula01-21-2010
20100168104HIV INHIBITING 5-AMIDO SUBSTITUTED PYRIMIDINES - This invention concerns pyrimidine derivatives of formula07-01-2010
20100234375HIV INHIBITING 5-(HYDROXYMETHYLENE AND AMINOMETHYLENE) SUBSTITUTED PYRIMIDINES - This invention concerns 5-(hydroxymethylene and aminomethylene)pyrimidine derivatives having HIV (Human Immunodeficiency Virus) replication inhibiting properties, to the preparation thereof and to pharmaceutical compositions comprising these compounds.09-16-2010
20100261722HIV INHIBITING 5, 6-SUBSTITUTED PYRIMIDINES - HIV replication inhibitors of formula10-14-2010
201101246736-ALKENYL AND 6-PHENYLALKYL SUBSTITUTED 2-QUINOLINONES AND 2-QUINOXALINONES AS POLY(ADP-RIBOSE) POLYMERASE INHIBITORS - The present invention provides compounds of formula (I) and compounds of formula (VII-a) as well as pharmaceutical compositions comprising said compounds and their use as PARP inhibitors05-26-2011

Jerôme Emile Georges Guillemont, Andé FR

Patent application numberDescriptionPublished
20090181993HIV INHIBITING 5-HETEROCYCLYL PYRIMIDINES - HIV replication inhibitors of formula (I), N-oxides, pharmaceutically acceptable addition salts, quaternary amines or stereoisomeric forms thereof, wherein -a07-16-2009

Jérôme Emile Georges Guillemont, Ande FR

Patent application numberDescriptionPublished
20100029679ANTIBACTERIAL QUINOLINE DERIVATIVES - The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib):02-04-2010
20100048566ANTIBACTERIAL QUINOLINE DERIVATIVES - The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib):02-25-2010
20100063026ANTIBACTERIAL QUINOLINE DERIVATIVES - The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib):03-11-2010
20100063061ANTIBACTERIAL QUINOLINE DERIVATIVES - The present invention relates to novel substituted quinoline derivatives according to the general formula (Ia) or formula (Ib):03-11-2010
20100069366ANTIBACTERIAL QUINOLINE DERIVATIVES - The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib):03-18-2010
20100197727Quinoline Derivatives as Antibacterial Agents - Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib)08-05-2010
20100204270Quinoline Derivatives as Antibacterial Agents - Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib) a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, a tautomeric form thereof or a N-oxide form thereof. Several of these compounds are also claimed as such. Further the combination of the above compounds with other antibacterial agents is described08-12-2010
20110008434SALT OF 4-[[4-[[4-(2-CYANOETHENYL)-2,6-DIMETHYLPHENYL]AMINO]-2-PYRIMIDINYL- ]AMINO]BENZONITRILE - The present invention relates to a pharmaceutical composition comprising as active ingredient the hydrochloric acid salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethyl-phenyl]amino]-2-pyrimidinyl]amino]benzonitrile and to processes for their preparation.01-13-2011
20110124870NOVEL MYCOBACTERIAL INHIBITORS - The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or the general Formula (Ib)05-26-2011

Jérôme Emile Georges Guillemont, Val De Reuil Cedex FR

Patent application numberDescriptionPublished
20110166179ANTIBACTERIAL QUINOLINE DERIVATIVES - The present invention relates to novel substituted quinoline derivatives according to the general formula (Ia) or formula (Ib):07-07-2011